Aspen Aerogels (ASPN) Expected to Announce Earnings on Wednesday

by · The Markets Daily

Aspen Aerogels (NYSE:ASPN – Get Free Report) is anticipated to post its Q4 2025 results before the market opens on Wednesday, February 25th. Analysts expect Aspen Aerogels to post earnings of ($0.24) per share and revenue of $44.2530 million for the quarter. Investors can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Wednesday, February 25, 2026 at 8:30 AM ET.

Aspen Aerogels Stock Performance

Shares of NYSE ASPN opened at $3.54 on Tuesday. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33. Aspen Aerogels has a one year low of $2.80 and a one year high of $9.78. The business’s 50-day moving average price is $3.31 and its two-hundred day moving average price is $5.13. The company has a market capitalization of $292.17 million, a P/E ratio of -0.95 and a beta of 2.99.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th. Barclays cut their price objective on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research report on Friday, November 7th. Zacks Research raised shares of Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 15th. Finally, Canaccord Genuity Group dropped their price target on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a research note on Friday, November 7th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $6.67.

Check Out Our Latest Research Report on Aspen Aerogels

Institutional Trading of Aspen Aerogels

A number of institutional investors and hedge funds have recently modified their holdings of the company. Creative Planning bought a new position in Aspen Aerogels in the 2nd quarter worth approximately $91,000. Caxton Associates LLP bought a new position in Aspen Aerogels during the first quarter worth $307,000. American Century Companies Inc. acquired a new position in Aspen Aerogels during the 2nd quarter valued at $89,000. Integrated Wealth Concepts LLC acquired a new position in Aspen Aerogels during the 1st quarter valued at $84,000. Finally, Occudo Quantitative Strategies LP bought a new stake in Aspen Aerogels in the 3rd quarter valued at $72,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

See Also